phase3 lakh virus products adults expert covishield dcgis ella govt icmr covaxin gambia regulatory pfizer sources nasal 612 market months novavax world likely official delivery health premature developed started dcgi

Articles for Dcgi, search results for covishield

Covovax to be available on CoWIN as booster dose soon. Check details
1 year, 8 months ago

Covovax to be available on CoWIN as booster dose soon. Check details

Hindustan Times  

In view of rising cases of COVID-19 in various parts of the country, Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Institute’s Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday. According to an official source, Singh had mentioned in his letter to the ministry that …

India Approved Dcgi Dose Covishield Covovax
DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose
1 year, 11 months ago

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose

News 18  

The Drug Controller General of India has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, official sources said on Monday. Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India, had recently written to the DCGI for the approval …

India Covid Dcgi Sii Covovax Booster Dose Heterologous Booster Dose
SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose
2 years ago

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose

News 18  

The Serum Institute of India has sought the drug regulator’s approval for market authorisation of its COVID-19 vaccine Covovax as a booster dose for those aged 18 years and above who have been administered two doses of Covishield or Covaxin, official sources said on Thursday. Prakash Kumar Singh, director, government and regulatory affairs, SII, submitted a market authorisation application for …

India Covid Dcgi Sii Covovax Booster Dose Market Authorisation
As Indians Choose to Ignore Booster Shots, Pace of Vaccine Testing Slows Down at Himachal Lab
2 years, 6 months ago

As Indians Choose to Ignore Booster Shots, Pace of Vaccine Testing Slows Down at Himachal Lab

News 18  

As India grapples to boost coverage of precaution dose, the pace of vaccine testing seems to be coming down at the country’s apex laboratory in Himachal Pradesh, News18.com has learnt. Currently, the lab is testing batches of Biological E’s Corbevax, which has been approved for kids starting 5 years and is awaiting more clearances for heterologous booster shot. THE CURIOUS …

India Booster Dcgi 18 Years Booster Shot Lakh Doses
Corbevax gets DCGI nod as COVID-19 booster after two doses of Covishield or Covaxin
2 years, 6 months ago

Corbevax gets DCGI nod as COVID-19 booster after two doses of Covishield or Covaxin

The Hindu  

Hyderabad-based Biological E. Limited ’s COVID-19 vaccine Corbevax has been approved by the Drug Controller General of India as a heterologous COVID-19 booster dose to individuals aged 18 years and above after 6 months of administration of primary vaccination of Covaxin or Covishield vaccines for restricted use in emergency situations. ‘’Recently, BE furnished its clinical trials data to the DCGI, …

India Vaccine Doses Covishield Corbevax Booster Dose Two Doses
Corbevax Gets DCGI Approval As Covid-19 Vaccine Booster Dose For 18 Years And Above
2 years, 6 months ago

Corbevax Gets DCGI Approval As Covid-19 Vaccine Booster Dose For 18 Years And Above

ABP News  

New Delhi: The Drug Controller General of India approved the Corbevax Covid-19 booster as heterologous Covid-19 booster dose for adults above the age of 18 years who got their primary Covid-19 vaccination of Covishield or Covaxin administered six months before, reported news agency ANI. Recently, BE has furnished its clinical trials data to the DCGI who after a detailed evaluation …

India Covid Booster Dose Corbevax Gets Dcgi
India's drugs regulator approves phase-3 trial of covid vaccine covovax
2 years, 9 months ago

India's drugs regulator approves phase-3 trial of covid vaccine covovax

India Today  

The Drugs Controller General of India granted permission on Wednesday for conducting the phase-3 clinical trial of Covid-19 vaccine Covovax as a booster dose in adults, official sources said. The Subject Expert Committee on Covid-19 of the Central Drugs Standard Control Organisation had, on March 5, recommended permission for conducting the phase-3 clinical trial for Covovax as a booster dose …

India Covid Vaccine Booster Dcgi Covovax
Govt panel recommends granting emergency use authorisation to Covid vaccine Covovax for 12-17 age group
2 years, 9 months ago

Govt panel recommends granting emergency use authorisation to Covid vaccine Covovax for 12-17 age group

India Today  

An expert panel of the country's central drug authority has recommended granting emergency use authorisation to Serum Institute of India's Covid-19 vaccine Covovax for the 12-17 age group, official sources said on Friday. Prakash Kumar Singh, Director-Government and Regulatory Affairs at Serum Institute of India, had submitted an application to the DCGI on February 21, seeking EUA for Covovax for …

India Covid Singh Dcgi Serum Institute Emergency Use Covovax
Govt Panel Recommends Emergency Approval For Covid Vaccine Corbevax For 12-18 Age Group
2 years, 10 months ago

Govt Panel Recommends Emergency Approval For Covid Vaccine Corbevax For 12-18 Age Group

ABP News  

New Delhi: An expert panel of India's central drug authority recommended on Monday that Biological E's Covid-19 vaccine, Corbevax, be granted restricted emergency use authorisation for the age group 12 to 18 years, PTI reported. On December 28 last year, the Drugs Controller General of India granted emergency use authorisation to Corbevax, India's first indigenously manufactured RBD protein sub-unit vaccine …

India Age Covid Pti Vaccine Dcgi Corbevax
Covishield, Covaxin get conditional market nod
2 years, 10 months ago

Covishield, Covaxin get conditional market nod

Hindustan Times  

The Drugs Controller General of India, India’s pharmaceuticals regulator, granted a conditional market authorisation for Covishield and Covaxin, the two coronavirus vaccines widely used in the country, officials said on Thursday. “The @CDSCO_INDIA_INF has now upgraded the permission for Covaxin and Covishield from restricted use in emergency situations to normal new drug permission in the adult population with certain conditions,” …

Health India Market Vaccines Pti Approval Vaccine
Covishield, Covaxin get govt expert panel's recommendation for regular market approval
2 years, 11 months ago

Covishield, Covaxin get govt expert panel's recommendation for regular market approval

India TV News  

Highlights A DCGI Committee recommended regular market approval to Covishield and Covaxin Covishield and Covaxin are currently only authorised for emergency use in the country SII and Bharat Biotech submitted applications to DCGI seeking regular market approval An expert panel of India's central drug authority on Wednesday recommended granting regular market approval to Covid vaccines Covishield and Covaxin, which are …

Singh Expert Sec Approval Bharat Biotech Covaxin Covishield
Bharat Biotech's nasal Covid booster dose gets DCGI approval for Phase III trial
2 years, 11 months ago

Bharat Biotech's nasal Covid booster dose gets DCGI approval for Phase III trial

India TV News  

DCGI's Subject Expert Committee has granted 'in principle' approval to Bharat Biotech for the conduct of 'Phase III superiority study and Phase III booster dose study' for its intranasal COVID vaccine and has asked it to submit protocols for approval, according to news agency ANI. According to reports, the Hyderabad-based biotechnology company had earlier proposed that its nasal vaccine can …

India Covid Booster Bharat Biotech Dose Nasal Vaccine
Bharat Biotech Seeks DCGI Nod for Trials to Evaluate Efficacy of Covaxin Booster Shot - News18
2 years, 11 months ago

Bharat Biotech Seeks DCGI Nod for Trials to Evaluate Efficacy of Covaxin Booster Shot - News18

News 18  

Bharat Biotech has sought permission from India’s drug regulator to conduct clinical trials for evaluating the efficacy of a third dose of its Covid-19 vaccine, Covaxin. According to a top government official, the indigenous vaccine maker has proposed to conduct clinical trials for Covaxin’s booster shot on 5,000 healthy volunteers, keeping a gap of six months between the second and …

India Booster Dcgi Dose Booster Shot Shot News18
Coxavin gets DCGI nod for use among 12-18 age group
2 years, 11 months ago

Coxavin gets DCGI nod for use among 12-18 age group

Hindustan Times  

New Delhi The Drugs Controller General of India on Saturday approved Covaxin for use in children between the ages of 12 and 18, a significant step towards opening vaccinations to the age group that has so far remained ineligible in India’s immunisation programme against Covid-19. The approval from DCGI came nearly 10 weeks after the subject expert committee of the …

India Children Age Vaccine Dcgi
Serum Institute seeks DCGI nod for Covid vaccine Covovax
3 years, 1 month ago

Serum Institute seeks DCGI nod for Covid vaccine Covovax

India Today  

The Serum Institute of India on Friday sought permission from the Drugs Controller General of India to manufacture Covid-19 vaccine Covovax for restricted use in emergency situations at its Manjari manufacturing site, official sources said. There were no safety concerns arising from the study data and Covovax is safe and immunogenic in the adult population, Prakash Kumar Singh, Director, Government …

Covid Vaccine Serum Institute Covovax India Sii Dcgi Nod
Biological E seeks DCGI’s nod for phase-3 trial of Corbevax as booster dose in those vaccinated with Covishield or Covax
3 years, 2 months ago

Biological E seeks DCGI’s nod for phase-3 trial of Corbevax as booster dose in those vaccinated with Covishield or Covax

Live Mint  

Hyderabad-based pharmaceutical company Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its COVID-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin. The company, meanwhile, has put in an application seeking the nod of the Drugs Controller General of India to conduct the …

India Vaccine Dcgi Clinical Biological E Covishield Corbevax
DCGI nod to phase-I clinical trial of COVID-19 vaccine of Reliance Life Sciences
3 years, 3 months ago

DCGI nod to phase-I clinical trial of COVID-19 vaccine of Reliance Life Sciences

The Hindu  

The Drugs Controller General of India on September 3 granted permission to the Mukesh Ambani-owned Reliance Life Sciences to conduct phase-I clinical trial of its indigenous COVID-19 vaccine with certain conditions, sources said. The phase-I clinical trial will be conducted to evaluate safety, tolerability and immunogenicity of the SARS-CoV-2 recombinant protein subunit vaccine in healthy volunteers according to protocol, they …

Trial Dcgi
Proposal to study mixing of Covaxin, Covishield approved by DCGI
3 years, 4 months ago

Proposal to study mixing of Covaxin, Covishield approved by DCGI

India TV News  

The Drugs Controller General Of India, India's drug regulator, has approved a proposal for a study to be conducted on the mixing of two COVID-19 vaccines -- Covishield and Covaxin. The aim of the study will be to assess the feasibility on whether a person can be given two different vaccine shots -- one each of Covishield and Covaxin -- …

India Medical Research Study Vaccine Dcgi Research Icmr Covaxin
Cipla gets DCGI nod to import Moderna's Covid vaccine for emergency use in India: Centre
3 years, 5 months ago

Cipla gets DCGI nod to import Moderna's Covid vaccine for emergency use in India: Centre

India TV News  

Mumbai-based pharmaceutical firm Cipla has received the Drugs Controller General of India nod to import Moderna’s COVID-19 vaccine for restricted emergency use in India, the Centre said on Tuesday. In separate communications, Moderna on June 27 informed DCGI that the US government has agreed to donate a certain number of doses of its COVID-19 vaccine through COVAX to India for …

India Vaccines Covid Vaccine Moderna Cipla Dcgi
Serum institute seeks permission to manufacture Sputnik V vaccine in India
3 years, 6 months ago

Serum institute seeks permission to manufacture Sputnik V vaccine in India

Firstpost  

SII said it will be able to manufacture and supply 10 crore Covishield doses in June while also manufacturing Novavax. The Serum Institute of India has applied to the Drug Controller General of India seeking permission to manufacture COVID-19 vaccine Sputnik V in the country, sources said on Thursday. “The Serum Institute of India put up an application to the …

India Vaccine Serum Dcgi Serum Institute Sii Manufacture
Covishield Producer SII Seeks DCGI Approval To Manufacture Sputnik V Covid Vaccine
3 years, 6 months ago

Covishield Producer SII Seeks DCGI Approval To Manufacture Sputnik V Covid Vaccine

ABP News  

Covid Vaccine Update: The Serum Insititute Of India which is manufacturing the Coronavirus vaccine Covishield has sought permission from the government to manufacture the Russian vaccine Sputnik V in India. "The Serum Institute of India put up an application to the Drugs Controller General of India on Wednesday seeking permission to manufacture the COVID-19 vaccine, Sputnik V, in India," a …

India Russia Covid Vaccine Dcgi Serum Institute Of India Serum Institute
Serum Institute Seeks DCGI's Nod to Manufacture Russian Vaccine Sputnik V in India
3 years, 6 months ago

Serum Institute Seeks DCGI's Nod to Manufacture Russian Vaccine Sputnik V in India

News 18  

After Oxford-AstraZeneca’s Covishield vaccine and Novovax’s Covovax, the Serum Institute of India on Wednesday has applied to get a nod from the Drug Controller General of India to make the Sputnik V Covid-19 vaccine in India. Recently, India received its latest consignment of nearly 3 million doses of the Sputnik V from Russia, making it the third and largest delivery …

India Dcgi Serum Institute Manufacture Sputnik V Vaccine Sputnik Russian V
Bharat Biotech seeks DCGI's nod to extend shelf life of Covaxin
3 years, 7 months ago

Bharat Biotech seeks DCGI's nod to extend shelf life of Covaxin

India TV News  

Bharat Biotech has written to India's drug regulator seeking extension of the shelf-life of its indigenously developed COVID-19 vaccine Covaxin from six to 24 months, sources said on Sunday. The Hyderabad-based Bharat Biotech was given permission for sale and distribution of Covaxin with shelf life of six months when stored at two to eight degrees Celsius. "Now, we are herewith …

India Life Bharat Shelf Dcgi Bharat Biotech Shelf Life
Sputnik V Cleared For Emergency Use in India: How Effective is It?
3 years, 8 months ago

Sputnik V Cleared For Emergency Use in India: How Effective is It?

The Quint  

Russian COVID-19 vaccine Sputnik V has been approved for emergency use authorisation in India, the Russian Direct Investment Fund said in a press release on Tuesday, 13 April. The RDIF announced on Tuesday that Drug Controller General of India has approved the use of the vaccine against coronavirus in India. On Monday, 12 April, the Subject Expert Committee approved Dr …

India Sec Dcgi Emergency Use Sputnik V Vaccine Sputnik